Loading company…
Wondercel Therapeutics develops cell and gene therapies for tumors, organ transplantation and autoimmune diseases.
Wondercel Therapeutics develops immune cell therapies intended to address tumors, organ transplantation and autoimmune diseases. Founded in 2022 and based in Shenzhen, China, it raised CNY 140 million in Series A funding in July 2026, led by Green Pine Capital Partners with Oriental Fortune Capital participating. The funding will support upcoming clinical trials and cell therapy development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in